321 related articles for article (PubMed ID: 21956798)
1. The chemistry and biology of trypanosomal trans-sialidases: virulence factors in Chagas disease and sleeping sickness.
Schauer R; Kamerling JP
Chembiochem; 2011 Oct; 12(15):2246-64. PubMed ID: 21956798
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional properties of Trypanosoma trans-sialidase.
Schenkman S; Eichinger D; Pereira ME; Nussenzweig V
Annu Rev Microbiol; 1994; 48():499-523. PubMed ID: 7826016
[TBL] [Abstract][Full Text] [Related]
3. Trans-sialidase-like sequences from Trypanosoma congolense conserve most of the critical active site residues found in other trans-sialidases.
Tiralongo E; Martensen I; Grötzinger J; Tiralongo J; Schauer R
Biol Chem; 2003 Aug; 384(8):1203-13. PubMed ID: 12974389
[TBL] [Abstract][Full Text] [Related]
4. T rypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease.
Dc-Rubin SS; Schenkman S
Cell Microbiol; 2012 Oct; 14(10):1522-30. PubMed ID: 22747789
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
Miller BR; Roitberg AE
Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
[TBL] [Abstract][Full Text] [Related]
6. The trans-sialidase from the african trypanosome Trypanosoma brucei.
Montagna G; Cremona ML; Paris G; Amaya MF; Buschiazzo A; Alzari PM; Frasch AC
Eur J Biochem; 2002 Jun; 269(12):2941-50. PubMed ID: 12071958
[TBL] [Abstract][Full Text] [Related]
7. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
8. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
9. Identification of a second catalytically active trans-sialidase in Trypanosoma brucei.
Nakatani F; Morita YS; Ashida H; Nagamune K; Maeda Y; Kinoshita T
Biochem Biophys Res Commun; 2011 Nov; 415(2):421-5. PubMed ID: 22040733
[TBL] [Abstract][Full Text] [Related]
10. The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis.
Buschiazzo A; Amaya MF; Cremona ML; Frasch AC; Alzari PM
Mol Cell; 2002 Oct; 10(4):757-68. PubMed ID: 12419220
[TBL] [Abstract][Full Text] [Related]
11. Trypanosomal Trans-sialidases: Valuable Synthetic Tools and Targets for Medicinal Chemistry.
Meinke S; Thiem J
Top Curr Chem; 2015; 367():231-50. PubMed ID: 22648866
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of trans-sialidase TS1 variants from Trypanosoma congolense.
Koliwer-Brandl H; Gbem TT; Waespy M; Reichert O; Mandel P; Drebitz E; Dietz F; Kelm S
BMC Biochem; 2011 Jul; 12():39. PubMed ID: 21801439
[TBL] [Abstract][Full Text] [Related]
13. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.
Tribulatti MV; Mucci J; Van Rooijen N; Leguizamón MS; Campetella O
Infect Immun; 2005 Jan; 73(1):201-7. PubMed ID: 15618155
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase.
Amaya MF; Watts AG; Damager I; Wehenkel A; Nguyen T; Buschiazzo A; Paris G; Frasch AC; Withers SG; Alzari PM
Structure; 2004 May; 12(5):775-84. PubMed ID: 15130470
[TBL] [Abstract][Full Text] [Related]
15. Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.
Muiá RP; Yu H; Prescher JA; Hellman U; Chen X; Bertozzi CR; Campetella O
Glycobiology; 2010 Jul; 20(7):833-42. PubMed ID: 20354005
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling of T. rangeli, T. brucei gambiense, and T. evansi sialidases in complex with the DANA inhibitor.
Lima AH; Souza PR; Alencar N; Lameira J; Govender T; Kruger HG; Maguire GE; Alves CN
Chem Biol Drug Des; 2012 Jul; 80(1):114-20. PubMed ID: 22416952
[TBL] [Abstract][Full Text] [Related]
17. The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation.
Mucci J; Risso MG; Leguizamón MS; Frasch AC; Campetella O
Cell Microbiol; 2006 Jul; 8(7):1086-95. PubMed ID: 16819962
[TBL] [Abstract][Full Text] [Related]
18. The surface trans-sialidase family of Trypanosoma cruzi.
Cross GA; Takle GB
Annu Rev Microbiol; 1993; 47():385-411. PubMed ID: 8257103
[TBL] [Abstract][Full Text] [Related]
19. [Human African trypanosomiasis].
Dumas M; Bouteille B
C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
[TBL] [Abstract][Full Text] [Related]
20. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
Meinke S; Schroven A; Thiem J
Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
